A detailed history of Wellington Management Group LLP transactions in Haemonetics Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 4,201,565 shares of HAE stock, worth $357 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,201,565
Previous 3,837,863 9.48%
Holding current value
$357 Million
Previous $318 Million 6.35%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $26.4 Million - $33.3 Million
363,702 Added 9.48%
4,201,565 $338 Million
Q2 2024

Aug 13, 2024

SELL
$81.24 - $97.37 $35.2 Million - $42.2 Million
-433,001 Reduced 10.14%
3,837,863 $318 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $304 Million - $365 Million
4,270,864 New
4,270,864 $365 Million
Q4 2023

Feb 12, 2024

BUY
$80.59 - $92.61 $263 Million - $303 Million
3,268,083 New
3,268,083 $279 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $4.12 Million - $4.66 Million
-49,858 Reduced 1.55%
3,167,054 $284 Million
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $29.2 Million - $32.4 Million
-361,802 Reduced 10.11%
3,216,912 $274 Million
Q1 2023

May 12, 2023

SELL
$72.75 - $90.6 $33.2 Million - $41.3 Million
-456,039 Reduced 11.3%
3,578,714 $296 Million
Q4 2022

Feb 13, 2023

SELL
$73.85 - $86.14 $98.3 Million - $115 Million
-1,331,646 Reduced 24.81%
4,034,753 $317 Million
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $17.2 Million - $21.4 Million
-271,685 Reduced 4.82%
5,366,399 $397 Million
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $26 Million - $34.8 Million
-527,279 Reduced 8.55%
5,638,084 $367 Million
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $47.8 Million - $69 Million
1,091,484 Added 21.51%
6,165,363 $390 Million
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $41.1 Million - $61.9 Million
829,572 Added 19.55%
5,073,879 $269 Million
Q3 2021

Nov 15, 2021

BUY
$57.6 - $70.59 $31.9 Million - $39 Million
553,118 Added 14.98%
4,244,307 $300 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $117 Million - $268 Million
2,263,855 Added 158.61%
3,691,189 $246 Million
Q1 2021

May 17, 2021

BUY
$111.01 - $139.48 $6.99 Million - $8.79 Million
63,001 Added 4.62%
1,427,334 $158 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $8.95 Million - $12.1 Million
100,881 Added 7.98%
1,364,333 $162 Million
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $20.8 Million - $25.7 Million
-275,046 Reduced 17.88%
1,263,452 $110 Million
Q2 2020

Aug 14, 2020

SELL
$84.96 - $118.91 $60.7 Million - $84.9 Million
-713,894 Reduced 31.69%
1,538,498 $138 Million
Q1 2020

May 14, 2020

SELL
$74.34 - $121.82 $214 Million - $351 Million
-2,879,242 Reduced 56.11%
2,252,392 $224 Million
Q4 2019

Feb 11, 2020

BUY
$114.37 - $129.46 $587 Million - $664 Million
5,131,634 New
5,131,634 $590 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.